A biopharmaceutical/nutraceutical company developing therapeutic agents based on natural tocotrienols (T3), targeting global unmet market needs. Tocotrienols are members of the vitamin E family, and an essential nutrient for the body.
Market ready, planning commercialisation launch in 2016.
Investment Opportunities exist for strategic partnerships for this company.
firstname.lastname@example.org and email@example.com
(Dr Caroline Hong, Healthcare Project Consultant)
firstname.lastname@example.org (Hon Andrew Stoner, Healthcare Project Consultant)